February 6, 2023
Tag: Breast Cancer Clinical Program
January 25, 2023
Race and geography linked to different risks of breast cancer treatment delays
A study led by Katherine Reeder-Hayes, MD, MBA, MS, found that Black patients and patients living in certain regions experience greater delays.
January 24, 2023
HealthDay: Geographic Region Linked to Breast Cancer Treatment Delay
January 24, 2023
Medscape: Immune-Related Biomarkers Can Help Guide HER2+ Breast Cancer Tx
January 9, 2023
Study identifies molecular differences between primary breast cancer and its metastases
A multi-institutional national study has identified unique molecular features responsible for the development and progression of metastatic breast cancer.
January 9, 2023
ASCO Post: Immune System B Cells May Help to Predict Treatment Response Among Patients With HER2-Positive Breast Cancer
January 6, 2023
Precision Oncology News: Immune Signatures Outperform TILs for HER2-Positive Breast Cancer Prognoses
January 5, 2023
Medscape: Agents and Sequencing Decisions for HR+ Breast Cancer
January 5, 2023
Immune system B-cells can help predict HER2-positive breast cancer treatment response
Researchers report specific immune system cells can help them determine whether HER2-positive breast cancer will respond to treatment.
December 20, 2022